Loading...
Cookies & Privacy. This website uses cookies to ensure you get the best experience on our website.
Restrata is the first electrospun, 100% synthetic, fully resorbable matrix engineered to be structurally similar to human extracellular matrix (ECM), providing clinicians with a solution throughout the continuum of soft tissue repair.


Discover the power of electrospun fiber technology

Restrata Sheet

Restrata is an engineered, fully resorbable, electrospun fiber matrix whose architecture resembles human ECM and supports cell ingrowth, retention, and differentiation. Representing a new approach to the treatment of acute and chronic wounds, Restrata utilizes the advantages of synthetic construction to launch a new era in healing.

 

 

Restrata for Soft Tissue Healing

Product Benefits

  • Resists enzymatic degradation, maintaining its structure to support soft tissue formation before fully resorbing via hydrolysis1,3,6-8​
  • Is fully synthetic, free of human or animal tissue, and does not require temperature monitoring or tissue tracking12,14,26​
  • Performs in hostile wound environments1,9​
  • Demonstrates minimal inflammatory response, neovascularization, and organized collagen deposition in newly formed tissue following application of Restrata1,2,32​
  • Reports an average skin graft take rate of over 95% in a compendium of clinical publications of acute surgical wound reconstruction13
  • Supported by numerous peer-reviewed publications including Level I clinical evidence13
  • May offer cost efficiencies in the OR by reducing product applications and wastage with 3 form factors and 19 sizes

Indicated for wound management including surgical, full-thickness, and traumatic wounds12

  STR_tissue_stages.png

Restrata for Soft Tissue Reinforcement

Product Benefits

  • Designed to mitigate wound breakdown or dehiscence, potentiallyreducing complications in high-risk patients and threatened closures14,15,20,21
  • When implanted underneath a primary skin closure, offers subcutaneousmechanical support to support areas at risk of post-surgicalcomplications14,15
  • Tensile strength to human skin and maintains some strength for 7-10 daysafter implantation, reinforcing subcutaneous closure during the 5-10 daywindow where the risk of dehiscence is the greatest2,22-24,28,31

Indicated for implantation to reinforce soft tissue where weakness exists, in patients requiring soft tissue repair and/or reinforcement in plastics or reconstructive surgery14

 

Refer to the Product IFUs for a full list of indications, pre-cautions and warnings. 

STR_video_images.png

 

str_chart_v3

restrata_size_chart2.png

restrata_size_chart.png

 

 

References can be found on this page

Contact us to learn more

Get company updates and case studies delivered to your inbox
Sign Up
Revolutionizing Healing. Changing Lives.
  •  
Cerafix®, Covora®, and Restrata® are registered trademarks of Acera Surgical Inc.
  •